↓ Skip to main content

The TRAIL in the Treatment of Human Cancer: An Update on Clinical Trials

Overview of attention for article published in Frontiers in Molecular Biosciences, March 2021
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Above-average Attention Score compared to outputs of the same age and source (61st percentile)

Mentioned by

twitter
2 X users

Citations

dimensions_citation
84 Dimensions

Readers on

mendeley
112 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The TRAIL in the Treatment of Human Cancer: An Update on Clinical Trials
Published in
Frontiers in Molecular Biosciences, March 2021
DOI 10.3389/fmolb.2021.628332
Pubmed ID
Authors

Martin Snajdauf, Klara Havlova, Jiri Vachtenheim, Andrej Ozaniak, Robert Lischke, Jirina Bartunkova, Daniel Smrz, Zuzana Strizova

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 112 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 112 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 19 17%
Student > Master 11 10%
Student > Bachelor 11 10%
Researcher 10 9%
Student > Doctoral Student 6 5%
Other 12 11%
Unknown 43 38%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 29 26%
Medicine and Dentistry 8 7%
Chemistry 7 6%
Immunology and Microbiology 6 5%
Pharmacology, Toxicology and Pharmaceutical Science 5 4%
Other 11 10%
Unknown 46 41%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 January 2024.
All research outputs
#16,351,173
of 25,815,269 outputs
Outputs from Frontiers in Molecular Biosciences
#1,454
of 4,768 outputs
Outputs of similar age
#254,709
of 455,818 outputs
Outputs of similar age from Frontiers in Molecular Biosciences
#95
of 276 outputs
Altmetric has tracked 25,815,269 research outputs across all sources so far. This one is in the 34th percentile – i.e., 34% of other outputs scored the same or lower than it.
So far Altmetric has tracked 4,768 research outputs from this source. They receive a mean Attention Score of 3.6. This one has gotten more attention than average, scoring higher than 66% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 455,818 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 41st percentile – i.e., 41% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 276 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 61% of its contemporaries.